(May 14, 2019) We’re excited to announce that Dr. Mary-Claire King, who identified the germline BRCA1 mutation associated with hereditary breast and ovarian cancer, will be a keynote speaker at OCRA’s Ovarian Cancer National Conference!
Dr. King is a geneticist and professor at the University of Washington. Her work has helped change the way we think about cancer and genetics and its impact has been felt by the world as genetic testing becomes more widespread.
Here’s a sneak peek at what you can expect to learn about at this year’s National Conference, taking place July 12-14 in Seattle, WA:
- Research Updates and PARP inhibitors, Elizabeth Swisher, MD
- Immunotherapy, Oliver Dorigo, MD
- Ask the Experts, Barbara Goff, MD, David Gershenson, MD, and Gottfried Kocney, MD (extended to two hours!)
- Nutrition, Gretchen Greunder, MS, RDN, CSO
- Stress Management, Bonnie McGregor, PhD
- Genetics 101, Mercy Laurino, MS, CGC, PhD
A full agenda will be available in June.
OCRA’s Ovarian Cancer National Conference brings together ovarian cancer survivors, caregivers, supporters and experts for an unforgettable weekend of new information, resources, friendship and hope. Don’t miss the biggest conference for the ovarian cancer community.
A limited number of rooms are available at a special discount rate at the Hyatt Regency Seattle, as well as travel discounts from our partners Delta Air Lines and United Airlines. Don’t wait – register today.